Ident. | Authors (with country if any) | Title |
---|
000020 (2020) |
Dylan Juckel [France] ; Jean Dubuisson [France] ; Sandrine Belouzard [France] | [Coronavirus, emerging viruses]. |
000074 (2020) |
Md Tanvir Kabir [Bangladesh] ; Md Sahab Uddin [Bangladesh] ; Md Farhad Hossain [Bangladesh, Corée du Sud] ; Jawaher A. Abdulhakim [Arabie saoudite] ; Md Asraful Alam [République populaire de Chine] ; Ghulam Md Ashraf [Arabie saoudite] ; Simona G. Bungau [Roumanie] ; May N. Bin-Jumah [Arabie saoudite] ; Mohamed M. Abdel-Daim [Arabie saoudite, Égypte] ; Lotfi Aleya [France] | nCOVID-19 Pandemic: From Molecular Pathogenesis to Potential Investigational Therapeutics. |
000157 (2020) |
P. Charlier [France] ; S. Donell [Royaume-Uni] ; D. Lippi [France, Italie] ; A. Nerlich [Allemagne] ; V. Asensi [France, Espagne] ; A. Perciaccante [France, Italie] ; O. Appenzeller [France, États-Unis] ; R. Bianucci [France, Royaume-Uni, Italie] | [Hydroxy-chloroquine to treat COVID-19 - infected patients: some lessons from medical anthropology and history of medicine]. |
000183 (2020) |
Christophe Kosinski [Suisse] ; Anne Zanchi [Suisse] ; Anne Wojtusciszyn [Suisse, France] | [Diabetes and COVID-19 infection]. |
000304 (2020) |
Sanjay Beesoon [Canada] ; Nemeshwaree Behary [France] ; Anne Perwuelz [France] | Universal masking during COVID-19 pandemic: Can textile engineering help public health? Narrative review of the evidence. |
000321 (2020) |
Erwan Sallard [France] ; François-Xavier Lescure [France] ; Yazdan Yazdanpanah [France] ; France Mentre [France] ; Nathan Peiffer-Smadja [France] | Type 1 interferons as a potential treatment against COVID-19. |
000328 (2020) |
Pierre-Jean Ferron [France] ; Thomas Gicquel [France] ; Bruno Mégarbane [France] ; Bruno Clément [France] ; Bernard Fromenty [France] | Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury? |
000349 (2020) |
J-M Michot [France] ; L. Albiges ; N. Chaput ; V. Saada ; F. Pommeret ; F. Griscelli ; C. Balleyguier ; B. Besse ; A. Marabelle ; F. Netzer [France] ; M. Merad ; C. Robert ; F. Barlesi ; B. Gachot [France] ; A. Stoclin [France] | Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report. |
000361 (2020) |
Marie-Christine Copin [France] ; Erika Parmentier [France] ; Thibault Duburcq [France] ; Julien Poissy [France] ; Daniel Mathieu [France] | Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection. |
000478 (2020) |
Jean-Jacques Tuech [France] ; Alice Gangloff [France] ; Frederic Di Fiore [France] ; Ahmed Benyoucef [France] ; Pierre Michel [France] ; Lilian Schwarz [France] | The Day after Tomorrow: How Should We Address Health System Organization to Treat Cancer Patients after the Peak of the COVID-19 Epidemic? |
000510 (2020) |
Sophie Alexandra Baron [France] ; Christian Devaux [France] ; Philippe Colson [France] ; Didier Raoult [France] ; Jean-Marc Rolain [France] | Teicoplanin: an alternative drug for the treatment of COVID-19? |
000567 (2020) |
Mathilde M. Husky [France] ; Viviane Kovess-Masfety [France] ; Joel D. Swendsen [France] | Stress and anxiety among university students in France during Covid-19 mandatory confinement. |
000597 (2020) |
Ahmed S. Gouda [Égypte] ; Bruno Mégarbane [France] | Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19? |
000634 (2020) |
Ferdinando D'Amico [Italie, France] ; Patrick Netter [France] ; Cedric Baumann [France] ; Muriel Veltin [France] ; Camille Zallot [France] ; Isabelle Aimone-Gastin [France] ; Silvio Danese [Italie] ; Laurent Peyrin-Biroulet [France] | Setting up a Virtual Calprotectin Clinic in Inflammatory Bowel Diseases: Literature Review and Nancy Experience. |
000675 (2020) |
Jean-Michel Pawlotsky [France] | SARS-CoV-2 pandemic : Time to revive the cyclophilin inhibitor alisporivir. |
000759 (2020) |
M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France] | Repurposing chlorpromazine to treat COVID-19: The reCoVery study. |
000951 (2020) |
Markus Zeitlinger [Autriche] ; Birgit C P. Koch [Pays-Bas] ; Roger Bruggemann [Pays-Bas] ; Pieter De Cock [Belgique] ; Timothy Felton [Royaume-Uni] ; Maya Hites [Belgique] ; Jennifer Le [États-Unis] ; Sonia Luque [Espagne] ; Alasdair P. Macgowan [Royaume-Uni] ; Deborah J E. Marriott [Australie] ; Anouk E. Muller [Pays-Bas] ; Kristina Nadrah [Slovénie] ; David L. Paterson [Australie] ; Joseph F. Standing [Royaume-Uni] ; João P. Telles [Brésil] ; Michael Wölfl-Duchek [Autriche] ; Michael Thy [France] ; Jason A. Roberts [Australie, France] | Pharmacokinetics/Pharmacodynamics of Antiviral Agents Used to Treat SARS-CoV-2 and Their Potential Interaction with Drugs and Other Supportive Measures: A Comprehensive Review by the PK/PD of Anti-Infectives Study Group of the European Society of Antimicrobial Agents. |
000952 (2020) |
Minh Patrick Lê [France] ; Pierre Jaquet [France] ; Juliette Patrier [France] ; Paul-Henri Wicky [France] ; Quentin Le Hingrat [France] ; Marc Veyrier [France] ; Juliette Kauv [France] ; Romain Sonneville [France] ; Benoit Visseaux [France] ; Cédric Laouénan [France] ; Lila Bouadma [France] ; Diane Descamps [France] ; Etienne De Montmollin [France] ; Gilles Peytavin [France] ; Jean-François Timsit [France] | Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients. |
000B76 (2020) |
Abdollahi H [Iran] ; Shiri I [Suisse] ; Bevelacqua J J [États-Unis] ; Jafarzadeh A [Iran] ; Rahmim A [Canada] ; Zaidi H [Suisse, Pays-Bas, Danemark] ; Mortazavi S A R [Iran] ; Mortazavi S M J [Iran] | Low Dose Radiation Therapy and Convalescent Plasma: How a Hybrid Method May Maximize Benefits for COVID-19 Patients. |
000C99 (2020) |
Julien Andreani [France] ; Marion Le Bideau [France] ; Isabelle Duflot [France] ; Priscilla Jardot [France] ; Clara Rolland [France] ; Manon Boxberger [France] ; Nathalie Wurtz [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Didier Raoult [France] | In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect. |
000D00 (2020) |
Franck Touret [France] ; Magali Gilles [France] ; Karine Barral [France] ; Antoine Nougairède [France] ; Jacques Van Helden [France] ; Etienne Decroly [France] ; Xavier De Lamballerie [France] ; Bruno Coutard [France] | In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication. |